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analyzed using intracellular cytokine staining (ICCS) on the CD4 + population. For IFN-γ and IL-17A ICCS. T cells were re-activated with 50 ng/ml of Phorbol 12,13-dibutyrate (Sigma-Aldrich) and 1µM of ionomycin (Sigma-Aldrich) for 4 (Th1) or 5 (Th17) hours in the presence of Golgi-stop ™ (BD Biosciences) during the last 4 hours. Cells were then surface stained with PE-labeled anti-CD4 antibody (BD Biosciences) and, subsequently, with APC-conjugated anti-IFN-γ antibody (BD Biosciences) or IL-17A antibody (eBioscience, San Diego, CA) using the Cytofix/Cytoperm kit (BD Biosciences) according to the manufacturer's instructions.
PDAC ® Cells or PDAC ® -CM Incubation with Human MoDC During Maturation
MoDC were generated as described in Methods. On day 3 of the MoDC culture, PDAC ® cells were seeded at 1.5x10 5 /ml in 2ml of RPMI-10 media in a 6-well CellBIND ® culture plate (Corning, Tewksbury, MA) in the presence of 1 ng/ml IL-1β (PeproTech, Rocky Hill, NJ) which significantly enhances PDAC ® cell potency in immunomodualtion in vitro (data not shown) and remarkably augment PGE 2 production by PDAC ® cells (data not shown). After 24 hours, condition medium of IL-1β-spiked PDAC ® cells (IL-1β-PDAC ® -CM) was collected. iDC were harvested on day 4 of the MoDC differentiation culture. For co-culture incubations, iDC were re-seeded at 1.5x10 5 /ml in 2ml of RPMI-10 media into wells that had been pre-seeded with PDAC ® cells. For conditioned medium incubations, iDC were re-seeded at 1.5x10 5 /ml in 2ml of RPMI-10 containing 50% or 25% IL-1β-PDAC ® -CM in 6-well CellBIND ® culture plates. iDC were stimulated with 0.5µg/ml LPS (Sigma-Aldrich) and 10ng/ml recombinant human IFN-γ (BD Biosciences) for maturation. After 24 hours, supernatant was collected for IL-12 and TNF-α CBA analysis in duplicate using the BD cytometric bead array Human Inflammatory Cytokines Kit (BD Biosciences) under manufacturer's instruction. mDC were harvested and stained with anti-human CD11c (eBioscience ), HLA-DR (eBioscience), CD86 (BD Biosciences), and CD83 (BD Biosciences).
Co-culture of PDAC ® Cells with PBMC
PDAC ® cells were resuspended at 1x10 5 /ml, followed by a series of dilutions (1:3 dilutions) with RPMI-10 media. Then one ml of PDAC ® cell suspension at various concentrations prepared as above was seeded in a 24-well CellBIND culture plate (Corning). After 24 hours, the supernatant of PDAC ® cell culture was removed, and 0.5ml of PBMC resuspended at 1x10 6 /ml in RPMI-10 media were seeded into wells containing PDAC ® cells in the presence of LPS at 10ng/ml (Sigma-Aldrich). The supernatant of each well was collected after 24-hour incubation. IL-23 in the supernatant was measured in duplicate using the human IL-23 sandwich ELISA Ready-SET-Go! ® Set (eBioscience).
Co-Culture of PDAC ® Cells with Monocytes During MoDC Differentiation
PDAC ® cells were mixed with 4-6 x10 6 monocytes at individual PDAC ® cell:monocyte ratios ranging from 1:10 to 1:5000 in a total volume of 10ml of RPMI-10 media. The mixed cell populations were plated onto a petri dish and cultured in the presence of 20ng/ml GM-CSF (PeproTech) and 40ng/ml IL-4 (R&D Systems). After 4 days, the iDC were harvested by gentle rinse and analyzed using flow cytometry to determine the iDC phenotype. To generate mDC, 3x10 5 iDC were re-seeded at day 4 into 6-well tissue culture plates and incubated for 24 hours with 0.5µg/ml LPS (from the Escherichia coli 0111:B4 strain;
Sigma-Aldrich) in combination with 10ng/ml recombinant human IFN-γ (BD Biosciences). 
| P a g e

